Find policies, billing codes, payers, states, and providers
CPT 0821T: Concurrent In-Person Monitoring During Psychedelic Medication Therapy
CPT code 0821T designates an hourly service in which a second physician or other qualified healthcare professional (QHP) provides continuous, in-person monitoring and intervention concurrent with a primary clinician during psychedelic medication therapy. The code recognizes the need for an additional clinician to manage potential emotional and physiological events that may occur during these sessions and establishes a billing mechanism for that dedicated, hourly presence. Nationally, this code matters as psychedelic-assisted therapies expand in clinical settings and payers evaluate coverage and payment policies for multi-clinician care models.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how the code is defined, typical service settings and clinical rationale, and which payers are relevant to coverage discussions. The publication also summarizes expected benchmarking topics, potential policy considerations affecting adoption, and the clinical context for physician staffing during psychedelic medication sessions.
Data not available in the input for specific modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service-line billing detail. The report focuses on the code definition, service implications, and payer landscape at a national level.
Customize your policy alerts
Sign up for cpt 0821T policy alerts
Get alerted when payer policies referencing 0821T are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 0821T describes a second physician or other qualified healthcare professional (QHP) who provides continuous, in-person monitoring and intervention concurrent with a first physician or QHP during a patient’s psychedelic medication therapy. This service is reported per hour and is intended to address potential emotional and physiological issues that can arise during the therapy.
Service Type: Concurrent in-person monitoring and intervention during psychedelic medication therapy
Typical Site of Service: Behavioral health or procedural setting where supervised psychedelic-assisted therapy is delivered, including inpatient or outpatient treatment areas staffed for continuous monitoring